Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31509242 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL652603 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL3407397 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL3469393 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL181032 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL14484285 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL19058823 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL650705 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL872663 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB | |
| SCHEMBL31509410 | 1.00 | ACE2 (0.58) | ACE2OPRM1LMNATSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060557-A | Preparation method of gamma-quinacridone organic pigment with high hiding power | 绍兴上虞新利化工有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-4275042-A1 | DETECTION OF RESPIRATORY TRACT INFECTIONS (RTIS) | Nanose Medical Ltd (IL) | 2023-11-15 | — | — | EP | claimed |
| WO-2022149132-A1 | DETECTION OF RESPIRATORY TRACT INFECTIONS (RTIS) | NANOSE MEDICAL LTD (IL) | 2022-07-14 | — | — | WO | claimed |
| US-20160068638-A1 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | NOVOMER, INC. | 2016-03-10 | — | — | US | claimed |
| EP-2992031-A2 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | Novomer, Inc. (US) | 2016-03-09 | — | — | EP | claimed |
| WO-2014178972-A2 | ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS | NOVOMER, INC. (US) | 2014-11-06 | — | — | WO | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122030497-A | Fermentation method for cooperatively treating ganoderma lucidum by bacterial enzymes and application of fermentation method in pet food | 杭州半边野兽科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-04-16 | — | — | US | disclosed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | disclosed |
| WO-2025126966-A1 | AQUEOUS COATING AGENT | HENKEL AG & CO. KGAA (DE) | 2025-06-19 | — | — | WO | disclosed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| US-20250163234-A1 | HEAT-EXPANDABLE MICROSPHERES AND USE THEREOF | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-1201632-A1 | FUSED RING COMPOUND | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-05-02 | — | — | EP | disclosed |
| EP-1191008-A1 | COMPOUND HAVING TETRAHYDRONAPHTHALENE SKELETON AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-03-27 | — | — | EP | disclosed |
| US-20020019562-A1 | Continuous processing | UOP LLC | 2002-02-14 | — | — | US | disclosed |
| WO-2001047837-A2 | CARBONYLATION PROCESS | UOP LLC (US) | 2001-07-05 | — | — | WO | disclosed |
| EP-0710684-B1 | Preparation process of polyhydroxycarboxylic acid | MITSUI CHEMICALS INC (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-5770683-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0710684-A2 | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | YAP1, CYP4F8, SCD | ACE2 3814/4885OPRM1 2937/4885LMNA 2968/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | ACE2 1833/4885OPRM1 855/4885LMNA 2460/4885 |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | ACE2 449/4885OPRM1 4200/4885LMNA 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.